|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 151.86 USD | +0.86% |
|
+2.43% | -47.82% |
| 24/11 | US health insurers buoyed by prospect of extended Obamacare subsidies | |
| 24/11 | Health insurers rise on report Trump considering ACA subsidy extension | RE |
| Capitalization | 780.56Cr 670.97Cr 628.55Cr 585.86Cr 1.08TCr 70TCr 1.18TCr 7.35TCr 2.84TCr 33TCr 2.93TCr 2.87TCr 1,21300Cr | P/E ratio 2025 * |
12.8x | P/E ratio 2026 * | 12.6x |
|---|---|---|---|---|---|
| Enterprise value | 696.6Cr 598.79Cr 560.94Cr 522.84Cr 965.7Cr 63TCr 1.05TCr 6.56TCr 2.53TCr 30TCr 2.61TCr 2.56TCr 1,08300Cr | EV / Sales 2025 * |
0.16x | EV / Sales 2026 * | 0.14x |
| Free-Float |
99.89% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Molina Healthcare, Inc.
| 1 day | +0.86% | ||
| 1 week | +2.43% | ||
| Current month | +2.43% | ||
| 1 month | -0.13% | ||
| 3 months | -13.05% | ||
| 6 months | -48.85% | ||
| Current year | -47.82% |
| 1 week | 142.28 | 152 | |
| 1 month | 133.4 | 152 | |
| Current year | 133.4 | 359.97 | |
| 1 year | 133.4 | 359.97 | |
| 3 years | 133.4 | 423.92 | |
| 5 years | 133.4 | 423.92 | |
| 10 years | 42.56 | 423.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joe Zubretsky
CEO | Chief Executive Officer | 68 | 06/11/2017 |
Mark Keim
DFI | Director of Finance/CFO | 59 | 17/02/2021 |
Jason Dees
CTO | Chief Tech/Sci/R&D Officer | - | 09/01/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Ronna Romney
BRD | Director/Board Member | 81 | 01/01/1999 |
Steven Orlando
BRD | Director/Board Member | 73 | 04/11/2005 |
Dale Wolf
CHM | Chairman | 71 | 02/05/2017 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.86% | +2.43% | -48.52% | -55.24% | 780.56Cr | ||
| -0.77% | +0.35% | -39.79% | -39.05% | 30TCr | ||
| -0.82% | -2.22% | -13.45% | -37.58% | 7.35TCr | ||
| -1.11% | -4.27% | -16.48% | -20.09% | 7.09TCr | ||
| +1.91% | +4.92% | -8.48% | -53.05% | 3.1TCr | ||
| -1.31% | -2.54% | -32.45% | -56.11% | 1.88TCr | ||
| +0.77% | +1.77% | +71.64% | +62.11% | 391.18Cr | ||
| -0.54% | -8.91% | +62.74% | -25.54% | 207.08Cr | ||
| -3.01% | +3.61% | -23.21% | +116.81% | 133.3Cr | ||
| -0.17% | -1.03% | -21.87% | - | 39Cr | ||
| Average | -0.42% | -0.70% | -6.99% | -11.97% | 5.1TCr | |
| Weighted average by Cap. | -0.65% | -0.48% | -29.37% | -36.69% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 4.49TCr 3.86TCr 3.61TCr 3.37TCr 6.22TCr 4,03900Cr 6.77TCr 42TCr 16TCr 1,90800Cr 17TCr 16TCr 6,97500Cr | 4.71TCr 4.05TCr 3.79TCr 3.53TCr 6.53TCr 4,23700Cr 7.1TCr 44TCr 17TCr 2,00100Cr 18TCr 17TCr 7,31700Cr |
| Net income | 63Cr 54Cr 51Cr 47Cr 87Cr 5.68TCr 95Cr 594.05Cr 229.37Cr 2.68TCr 236.71Cr 231.66Cr 9.8TCr | 61Cr 52Cr 49Cr 46Cr 84Cr 5.46TCr 91Cr 571.28Cr 220.58Cr 2.58TCr 227.64Cr 222.78Cr 9.43TCr |
| Net Debt | -84Cr -72Cr -68Cr -63Cr -116.4Cr -7.56TCr -126.61Cr -790.86Cr -305.36Cr -3.57TCr -315.14Cr -308.41Cr -13TCr | -123.14Cr -105.85Cr -99Cr -92Cr -170.71Cr -11TCr -185.68Cr -1.16TCr -447.83Cr -5.23TCr -462.16Cr -452.3Cr -19TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/25/05 | 151.86 $ | +0.86% | 9,60,945 |
| 04/25/04 | 150.57 $ | +0.99% | 10,83,698 |
| 03/25/03 | 149.09 $ | +2.14% | 11,47,108 |
| 02/25/02 | 145.97 $ | +0.67% | 18,36,767 |
| 01/25/01 | 145.00 $ | -2.20% | 16,33,442 |
Delayed Quote Nyse, December 06, 2025 at 02:30 am IST
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MOH Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















